Skip to main content

Table 2 Pharmacokinetic parameters of DOXol in control and ADI groups after single intravenous administration of DOX (7 mg/kg) (\( \overline{X} \) ± SD, n = 6)

From: Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma

Parameters

Control

ADI

AUC0-t (mg/L*h)

5.62 ± 2.23

16.41 ± 2.91**

MRT0-t (h)

2.40 ± 0.32

5.33 ± 1.31**

t1/2z (h)

2.09 ± 0.98

4.99 ± 0.95**

Tmax (h)

0.33 ± 0.001

0.33 ± 0.001

CLz/F (L/h/kg)

1.33 ± 0.57

0.43 ± 0.08

Vz/F (L/kg)

4.43 ± 3.86

3.13 ± 0.98

Cmax (mg/L)

2.41 ± 1.04

8.34 ± 3.90**

  1. Data are presented as mean ± SD (n = 6). **P < 0.01 versus control group
  2. AUC0-t, area under plasma drug concentration-time curve; MRT0-t, mean residence time; t1/2z, half-life of elimination; Tmax, peak time; CLz, clearance; Vz, apparent volume of distribution; Cmax, maximum (peak) plasma drug concentration